AsiaTIDES: Oligonucleotide and Peptide Therapeutics

Find R&D Innovations, Technologies and Partners to Advance Oligonucleotides and Peptides from Discovery through Manufacturing and Commercialization.

Day One

• Optional Workshop: Accelerating Oligonucleotides to IND and Beyond
• Optional Workshop: An Introduction to Peptide Therapeutic Development: Strategies for Moving to the Clinic, CMC and Beyond
• Plenary Keynote Presentations from Alnylam Pharmaceuticals, Novo Nordisk A/S, Ionis Pharmaceuticals, The University of Tokyo, Agilent Technologies
• Networking Dinner in Tokyo

Day Two

• Featured mRNA Therapeutics Session with speakers from Moderna Therapeutics, BioNTech AG, and CureVac AG
• Oligonucleotide Track: Optimizing Properties of Oligonucleotides/Oligonucleotide CMC Strategies
• Peptide Track: Peptide Discovery and Peptide Drug Targets/Peptide Synthesis/Optimizing Peptide Properties
• Evening Cocktail Networking Reception

Day Three

• NEW Regulatory Session from Fountain Medical Development, Regulatory Consulting, PPD, and Biologics Consulting Group
• Oligonucleotide Track: Delivery Strategies/Preclinical and Clinical Case Studies
• Peptide Track: Peptide CMC Strategies/Preclinical and Clinical Case Studies